Premium
Migraine and MTHFR C677T genotype in a population‐based sample
Author(s) -
Scher Ann I.,
Terwindt Gisela M.,
Verschuren W. M. Monique,
Kruit Mark C.,
Blom Henk J.,
Kowa Hisanori,
Frants Rune R.,
van den Maagdenberg Arn M. J. M.,
van Buchem Mark,
Ferrari Michel D.,
Launer Lenore J.
Publication year - 2006
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.20755
Subject(s) - odds ratio , methylenetetrahydrofolate reductase , migraine with aura , aura , genotype , migraine , medicine , confidence interval , risk factor , homocysteine , population , stroke (engine) , gastroenterology , genetics , biology , mechanical engineering , environmental health , engineering , gene
Objective Migraine with aura is associated with increased risk of stroke. The MTHFR C677T genotype has been associated with increased risk of migraine in selected clinical samples and with elevated homocysteine, a risk factor for stroke. We assessed the association of the MTHFR C677T variant with migraine and the mediating effect of cardiovascular risk factors and metabolic markers of genotype status. Methods We compared adult migraineurs with aura (MA; n = 187), without aura (MO; n = 226), and nonmigraineurs (n = 1,212) from the population‐based Genetic Epidemiology of Migraine study. Results Compared with the wild‐type genotype, the T/T genotype was associated with increased odds of MA (odds ratio [OR], 2.05; 95% confidence interval, 1.2–3.4; p < 0.006), with a trend of increasing numbers of T alleles (OR, 1.40; 95% confidence interval, 1.1–1.8; p < 0.007). ORs were slightly attenuated after adjusting for homocysteine. Interpretation Risk of MA is associated with MTHFR C674T homozygosity, independent of other cardiovascular risk factors. Ann Neurol 2006